These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4645074)

  • 1. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms].
    Perevodchikova NI; Platinskiĭ LV; Kertsman VI
    Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of adrenocortical cancer treated with O,P'-DDD.
    Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M
    Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD.
    Gustafsson JA; Lisboa BP
    Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical application of o.p' DDD to the case of adrenal cortex cancer].
    Naruse T; Sasaki T; Yamaoka T; Matsuoka K; Nekita H
    Horumon To Rinsho; 1970 Mar; 18(3):241-4. PubMed ID: 5464572
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
    Helson L; Wollner N; Murphy ML; Schwartz MK
    Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenal cortical carcinoma. Clinical features of 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):572-80. PubMed ID: 5923598
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone and androstenedione production rates in patients with metastatic adrenal cortical carcinoma.
    Bardin CW; Lipsett MB; French AM
    J Clin Endocrinol Metab; 1968 Feb; 28(2):215-20. PubMed ID: 5636152
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical picture, diagnosis and surgical treatment of hormonal-active tumors of the adrenal cortex].
    Nikolaev OV; Kertsman VI; Kalinin AP
    Khirurgiia (Mosk); 1966 Sep; 42(9):3-11. PubMed ID: 4300040
    [No Abstract]   [Full Text] [Related]  

  • 10. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 12. [Masculinizing tumors of the adrenal cortex in children before puberty].
    Decourt J; Anoussakis C
    Sem Hop; 1969 Mar; 45(13):817-26. PubMed ID: 4327255
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
    Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
    J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical treatment of canine hyperadrenocorticoidism with o,p'-DDD.
    Lorenz MD; Scott DW; Pulley LT
    Cornell Vet; 1973 Oct; 63(4):646-65. PubMed ID: 4748884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of a Cushing syndrome caused by hyperplasia of the adrenal cortex in a 7-year old girl with the adrenal cortex blocking agent opDDD ].
    Pichler E
    Helv Paediatr Acta; 1966 Nov; 21(5):447-74. PubMed ID: 5995803
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
    Kasperlik-Zaluska AA; Cichocki A
    J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chlodithane (o,p'-DDD) on transcortin binding ability in Itsenko-Cushing's disease].
    Tron'ko MD
    Fiziol Zh; 1970; 16(6):844-5. PubMed ID: 5520073
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonally acitve cancer of the adrenal cortex treated with o, p'-DDD].
    Hartwig W; Massalski W; Kasperlik-Zaluska A; Migdalska B; Szamatowicz M; Jakowicki J
    Endokrynol Pol; 1968; 19(2):187-200. PubMed ID: 5668901
    [No Abstract]   [Full Text] [Related]  

  • 19. o,p'DDD therapy in invasive adrenocortical carcinoma.
    Becker D; Schumacher OP
    Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of steroids in a 4 1/2-year-old boy with precocious puberty caused by adrenal gland carcinoma].
    Gleispach H; Alcaniz Cerrando JJ; Barcelo Lucerga B; Salto Hernandez L; Glatzl J
    Padiatr Grenzgeb; 1974; 13(4):265-9. PubMed ID: 4457768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.